Page last updated: 2024-08-21

alpha-aminopyridine and asp3026

alpha-aminopyridine has been researched along with asp3026 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ceccon, M; Chiriano, G; Gambacorti-Passerini, C; Mologni, L; Piazza, R; Pirola, A; Scapozza, L	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and asp3026

Article	Year
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922. Oncotarget, 2015, Mar-20, Volume: 6, Issue:8 Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Animals; Apoptosis; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetulus; Humans; Lactams; Lactams, Macrocyclic; Lymphoma, Large-Cell, Anaplastic; Models, Molecular; Mutation; Nuclear Proteins; Nucleophosmin; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Receptor Protein-Tyrosine Kinases; Signal Transduction; Sulfones; Triazines	2015

Article

Year

NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922.

Oncotarget, 2015, Mar-20, Volume: 6, Issue:8

Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Animals; Apoptosis; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetulus; Humans; Lactams; Lactams, Macrocyclic; Lymphoma, Large-Cell, Anaplastic; Models, Molecular; Mutation; Nuclear Proteins; Nucleophosmin; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Receptor Protein-Tyrosine Kinases; Signal Transduction; Sulfones; Triazines

2015